Abstract
Background: Maternal mortality remains a major healthcare challenge worldwide with 27% of all maternal deaths attributed to haemorrhage. Tranexamic acid (TXA) is widely available and has been shown to reduce the need for transfusion in elective surgery and bleeding related mortality in women who suffer a postpartum haemorrhage (PPH).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
